Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2016 16:02 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results

- Full-year 2015 Total BioMarin Revenue Increases 18.8% to $889.9 million Year-over-Year - Vimizim Net Product Revenue Contributes Over $228 million to 2015 Top-line - Full-year 2016 Total...